Manulife (Manufacturers Life Insurance)’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $279K | Buy |
38,915
+5,030
| +15% | +$36.1K | ﹤0.01% | 2416 |
|
2025
Q1 | $203K | Sell |
33,885
-388
| -1% | -$2.32K | ﹤0.01% | 2494 |
|
2024
Q4 | $267K | Sell |
34,273
-664
| -2% | -$5.18K | ﹤0.01% | 2503 |
|
2024
Q3 | $377K | Sell |
34,937
-815
| -2% | -$8.8K | ﹤0.01% | 2381 |
|
2024
Q2 | $301K | Buy |
35,752
+4,528
| +15% | +$38.2K | ﹤0.01% | 2421 |
|
2024
Q1 | $210K | Sell |
31,224
-8,321
| -21% | -$55.9K | ﹤0.01% | 2574 |
|
2023
Q4 | $233K | Sell |
39,545
-788
| -2% | -$4.63K | ﹤0.01% | 2537 |
|
2023
Q3 | $393K | Buy |
40,333
+13,257
| +49% | +$129K | ﹤0.01% | 2252 |
|
2023
Q2 | $321K | Buy |
27,076
+2,403
| +10% | +$28.5K | ﹤0.01% | 2312 |
|
2023
Q1 | $266K | Hold |
24,673
| – | – | ﹤0.01% | 2379 |
|
2022
Q4 | $285K | Buy |
24,673
+6,716
| +37% | +$77.6K | ﹤0.01% | 2340 |
|
2022
Q3 | $268K | Sell |
17,957
-486
| -3% | -$7.25K | ﹤0.01% | 2375 |
|
2022
Q2 | $166K | Buy |
18,443
+2,235
| +14% | +$20.2K | ﹤0.01% | 2738 |
|
2022
Q1 | $121K | Sell |
16,208
-4,060
| -20% | -$30.4K | ﹤0.01% | 2925 |
|
2021
Q4 | $174 | Sell |
20,268
-1,410
| -7% | -$12 | ﹤0.01% | 2940 |
|
2021
Q3 | $182K | Sell |
21,678
-1,557
| -7% | -$13.1K | ﹤0.01% | 3014 |
|
2021
Q2 | $188K | Buy |
+23,235
| New | +$188K | ﹤0.01% | 3138 |
|